There are 70 million undiagnosed OSA patients in USA.2,4 That means a screening process could uncover OSA risk in ~20% of your current patient base, many of whom will be candidates for OAT. Many more will be problem snorers looking for a professional solution.
Panthera Dental’s Patient Screening Assessment tool (coming soon) will help you identify those that snore and that are at risk of OSA, and determine their treatment pathway.
Potential candidates for OAT are:
- Patients who snore.
- Patients at risk of OSA and who, when tested, are diagnosed with mild or moderate OSA.
- Patients with severe OSA who are contraindicated for or can’t tolerate CPAP.
Note that insurers are likely to reimburse OAT for 2 and 3. But treatment for snoring will likely be paid for by the patient.